Moderna, Inc.
General ticker "MRNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.3B (TTM average)
Moderna, Inc. follows the US Stock Market performance with the rate: 45.0%.
Estimated limits based on current volatility of 4.5%: low 250.51$, high 273.86$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Total employees count: 4700 (-19.0%) as of 2025
- US accounted for 53.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Market competition, Manufacturing issues, Supply chain disruptions, Cybersecurity threats
- Current price 446.0% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.95$, 45.55$]
- 2026-12-31 to 2027-12-31 estimated range: [19.31$, 42.10$]
Financial Metrics affecting the MRNA estimates:
- Negative: with PPE of -4.4 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Investing cash flow per share per price, % of 15.76 > 2.40
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: 68.95 < Shareholder equity ratio, % of 70.11 <= 81.82
- Negative: negative Net income
- Negative: 1.39 < Inventory ratio change, % of 3.80
Short-term MRNA quotes
Relationship graph
Long-term MRNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6,848.00MM | $3,236.00MM | $1,944.00MM |
| Operating Expenses | $11,087.00MM | $7,181.00MM | $5,018.00MM |
| Operating Income | $-4,239.00MM | $-3,945.00MM | $-3,074.00MM |
| Non-Operating Income | $297.00MM | $338.00MM | $306.00MM |
| R&D Expense | $4,845.00MM | $4,543.00MM | $3,132.00MM |
| Income(Loss) | $-3,942.00MM | $-3,607.00MM | $-2,768.00MM |
| Taxes | $772.00MM | $-46.00MM | $54.00MM |
| Net Income(Loss)* | $-4,714.00MM | $-3,561.00MM | $-2,822.00MM |
| Stockholders Equity | $13,854.00MM | $10,901.00MM | $8,650.00MM |
| Inventory | $202.00MM | $117.00MM | $153.00MM |
| Assets | $18,426.00MM | $14,142.00MM | $12,338.00MM |
| Operating Cash Flow | $-3,118.00MM | $-3,004.00MM | $-1,873.00MM |
| Capital expenditure | $707.00MM | $1,051.00MM | $192.00MM |
| Investing Cash Flow | $4,206.00MM | $1,949.00MM | $1,946.00MM |
| Financing Cash Flow | $-1,377.00MM | $56.00MM | $593.00MM |
| Earnings Per Share** | $-12.34 | $-9.27 | $-7.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.